Method for producing steviol and steviol glycoside using AOBGL3 homolog

US10415071B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10415071-B2
Application numberUS-201615770896-A
CountryUS
Kind codeB2
Filing dateOct 28, 2016
Priority dateOct 30, 2015
Publication dateSep 17, 2019
Grant dateSep 17, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a method for preparing a steviol glycoside and/or steviol comprising reacting glycosidase AOBGL1 and/or AOBGL3 or a variant thereof with a steviol glycoside having at least one monoglucoside bond and/or monoglucosyl ester bond, thereby cleaving said monoglucoside bond and/or monoglucosyl ester bond.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing a steviol glycoside and/or steviol comprising reacting a protein selected from the group consisting of proteins (a) to (c) shown below with a steviol glycoside having at least one monoglucoside bond and/or monoglucosyl ester bond, thereby cleaving said monoglucoside bond and/or monoglucosyl ester bond: (a) a protein consisting of the amino acid sequence of SEQ ID NO: 3 or 4; (b) a protein having an amino acid sequence having 90% or more sequence identity to the amino acid sequence of SEQ ID NO: 3 or 4, and having an activity to cleave a monoglucoside bond and/or monoglucosyl ester bond of a steviol glycoside; and (c) a protein comprising the amino acid sequence of SEQ ID NO: 3 or 4. 2. The method according to claim 1 , wherein the steviol glycoside having at least one monoglucoside bond and/or monoglucosyl ester bond is selected from rebaudioside A, stevioside, rubusoside, steviolmonoside, and steviol monoglucosyl ester. 3. The method according to claim 2 , wherein the steviol glycoside to be prepared is selected from rebaudioside B and steviolbioside. 4. The method according to claim 1 , further comprising culturing a non-human transformant obtained by introducing a polynucleotide selected from the group consisting of polynucleotides (a) to (e) shown below into a host producing a steviol glycoside having at least one monoglucoside bond and/or monoglucosyl ester bond: (a) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (b) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 3 or 4; (c) a polynucleotide encoding a protein having an amino acid sequence having 90% or more sequence identity to the amino acid sequence of SEQ ID NO: 3 or 4, and having an activity to cleave a monoglucoside bond and/or monoglucosyl ester bond of a steviol glycoside; (d) a polynucleotide which hybridizes under highly stringent conditions to a polynucleotide consisting of a nucleotide sequence complementary to a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 and which encodes a protein having an activity to cleave a monoglucoside bond and/or monoglucosyl ester bond of a steviol glycoside, wherein highly stringent conditions include (i) 5×SSC, 5×Denhardt's solution, 0.5% SDS, 50% formamide, 50° C., (ii) 0.2×SSC, 0.1% SDS, 60° C.; 0.2×SSC, 0.1% SDS, 62° C., or (iii) 0.2×SSC, 0.1% SDS, 65° C.; and (e) a polynucleotide encoding a protein comprising the amino acid sequence of SEQ ID NO: 3 or 4. 5. The method according to claim 4 , wherein the polynucleotide is inserted into an expression vector. 6. The method according to claim 4 , wherein the transformant is transformed koji mold, transformed yeast, or a transformed plant. 7. The method according to claim 1 , wherein the protein is derived from a non-human transformed cell obtained by introducing, into a host cell, a polynucleotide selected from the group consisting of polynucleotides (a) to (e) shown below, with a steviol glycoside having at least one monoglucoside bond and/or monoglucosyl ester bond, thereby cleaving said monoglucoside bond and/or monoglucosyl ester bond: (a) a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1; (b) a polynucleotide encoding a protein consisting of the amino acid sequence of SEQ ID NO: 3 or 4; (c) a polynucleotide encoding a protein having an amino acid sequence having 90% or more sequence identity to the amino acid sequence of SEQ ID NO: 3 or 4, and having an activity to cleave a monoglucoside bond and/or monoglucosyl ester bond of a steviol glycoside; (d) a polynucleotide which hybridizes under highly stringent conditions to a polynucleotide consisting of a nucleotide sequence complementary to a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 1 and which encodes a protein having an activity to cleave a monoglucoside bond and/or monoglucosyl ester bond of a steviol glycoside, wherein highly stringent conditions include (i) 5×SSC, 5×Denhardt's solution, 0.5% SDS, 50% formamide, 50° C., (ii) 0.2×SSC, 0.1% SDS, 60° C.; 0.2×SSC, 0.1% SDS, 62° C., or (iii) 0.2×SSC, 0.1% SDS, 65° C.; and (e) a polynucleotide encoding a protein comprising the amino acid sequence of SEQ ID NO: 3 or 4. 8. The method according to claim 7 , wherein the polynucleotide is inserted into an expression vector. 9. The method according to claim 7 , wherein the transformed cell is transformed koji mold, a transformed bacterium, or transformed yeast. 10. The method according to claim 7 , wherein the steviol glycoside having at least one monoglucoside bond and/or monoglucosyl ester bond is selected from rebaudioside A, stevioside, rubusoside, steviolmonoside, and steviol monoglucosyl ester. 11. The method according to claim 10 , wherein the steviol glycoside to be prepared is selected from rebaudioside B and steviolbioside. 12. The method according to claim 1 , further comprising reacting a protein selected from the group consisting of proteins (d) to (f) shown below, and a steviol glycoside having an unbranched β-1,2-glucoside bond: (d) a protein consisting of the amino acid sequence of SEQ ID NO: 7 or 8; (e) a protein having an amino acid sequence having 90% or more sequence identity to the amino acid sequence of SEQ ID NO: 7 or 8, and having an activity to cleave an unbranched β-1,2-glucoside bond of a steviol glycoside; and (f) a protein comprising the amino acid sequence of SEQ ID NO: 7 or 8. 13. The method according to claim 12 , wherein the steviol glycoside having the unbranched β-1,2-glucoside bond comprises one or more steviol glycosides selected from rebaudioside D, rebaudioside E, stevioside, and steviolbioside.

Assignees

Inventors

Classifications

  • Recombinant DNA-technology · CPC title

  • acting on glycosyl compounds (3.2) · CPC title

  • Preparation of compounds containing at least three condensed carbocyclic rings {(gibbanes C12P27/00; naphthacenes C12P29/00)} · CPC title

  • containing a hydroxy group · CPC title

  • Monosaccharides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10415071B2 cover?
The present invention provides a method for preparing a steviol glycoside and/or steviol comprising reacting glycosidase AOBGL1 and/or AOBGL3 or a variant thereof with a steviol glycoside having at least one monoglucoside bond and/or monoglucosyl ester bond, thereby cleaving said monoglucoside bond and/or monoglucosyl ester bond.
Who is the assignee on this patent?
Suntory Holdings Ltd
What technology area does this patent fall under?
Primary CPC classification C12P19/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).